Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 19,838 | 1,213 | N/A | N/A |
| Receivables | 600 | N/A | N/A | N/A |
| Other current assets | 247 | 0 | 0 | 0 |
| TOTAL | $20,685 | $1,539 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 693 | N/A | N/A | N/A |
| Investments And Advances | 0 | 100,155 | 0 | 0 |
| Other Non-Current Assets | 1,979 | 0 | 0 | 0 |
| TOTAL | $2,672 | $100,155 | $N/A | $N/A |
| Total Assets | $23,357 | $101,694 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,417 | 95 | 0 | 0 |
| Accrued Expenses | 2,595 | N/A | N/A | N/A |
| TOTAL | $4,012 | $111 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 54,475 | 96,582 | 0 | 0 |
| TOTAL | $54,475 | $96,582 | $N/A | $N/A |
| Total Liabilities | $58,487 | $96,694 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 1,250 | N/A | N/A | N/A |
| Common Shares | 1 | 0 | N/A | N/A |
| Retained earnings | -36,813 | 2 | N/A | N/A |
| TOTAL | $-35,130 | $5,000 | $N/A | $N/A |
| Total Liabilities And Equity | $23,357 | $101,694 | $0 | $0 |